title: Inflammation and the heart - prime time for new therapeutic approaches.
abstract: BACKGROUND
  Atherosclerosis remains one of the main causes of cardiovascular disease.
  
  
  METHODS
  A brief overview of the work summarized by Berman et al. [Berman JP, Farkouh ME, Rosenson RS. Emerging anti-inflammatory drugs for atherosclerosis. Expert Opin Emerg Drugs 2013;18(2):193-205] on the development of anti-inflammatory drugs to tackle atherosclerosis is provided.
  
  
  CONCLUSIONS
  Indeed, recent data from clinical trials on anti-inflammatory drugs in coronary artery disease highlight the potential of such therapies.
authors.forename: François
authors.initials: F
authors.lastname: Roubille
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Tardif
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000188:drug therapy*; D006801:Humans
chemical_list: D000893:Anti-Inflammatory Agents